A novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI)

A novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI) AbbreviationsALBAlbuminALTAlanine aminotransferaseAPRIaspartate aminotransferase/platelet count ratio indexAPTTActivated partial prothrombin timeASTAspertate aminotransferaseAUCareas under the ROCAvailability of data and materialNot applicablecDFClassic dengue feverConsent for publicationNot applicableDFdengue feverDSSdengue shock syndromeDHFdengue hemorrhagic feverEthics statementNot applicablePLTplatelet countPTProthrombin timeROCReceiver Operating Characteristic CurveSDDsevere dengue diseasesSesensitivitySpspecificityTPTotal proteinWBCLeukocyte countINTRODUCTIONWith an estimated 390 million cases in over 100 countries and regions in Asia, Oceania, the Americas, and Africa, dengue fever (DF) is now among the most important vector‐borne diseases worldwide. Both the incidence and number of epidemic areas have increased significantly in recent years, particularly in Southeast Asia, the Pacific, and the Americas, making DF a major emerging infectious disease. DF presents with a wide clinical spectrum, ranging from a self‐limiting infection (85‐90% of cases) to severe dengue diseases (SDD), which occurs in approximately 5% of cases, and includes both dengue shock syndrome (DSS) and dengue hemorrhagic fever (DHF). There is no effective vaccine for the prevention of dengue infection, nor are there any antiviral agents or immune modulators that can reduce its mortality. However, with good supportive medical care, mortality rates of less than 1% can be achieved, even with the inclusion of DSS cases. Therefore, diagnostic indicators are important to ensure early SDD recognition. Published studies have reported http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Medical Virology Wiley

A novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI)

Loading next page...
 
/lp/wiley/a-novel-predictor-of-severe-dengue-the-aspartate-aminotransferase-2UgFe8Bd30
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
0146-6615
eISSN
1096-9071
D.O.I.
10.1002/jmv.25021
Publisher site
See Article on Publisher Site

Abstract

AbbreviationsALBAlbuminALTAlanine aminotransferaseAPRIaspartate aminotransferase/platelet count ratio indexAPTTActivated partial prothrombin timeASTAspertate aminotransferaseAUCareas under the ROCAvailability of data and materialNot applicablecDFClassic dengue feverConsent for publicationNot applicableDFdengue feverDSSdengue shock syndromeDHFdengue hemorrhagic feverEthics statementNot applicablePLTplatelet countPTProthrombin timeROCReceiver Operating Characteristic CurveSDDsevere dengue diseasesSesensitivitySpspecificityTPTotal proteinWBCLeukocyte countINTRODUCTIONWith an estimated 390 million cases in over 100 countries and regions in Asia, Oceania, the Americas, and Africa, dengue fever (DF) is now among the most important vector‐borne diseases worldwide. Both the incidence and number of epidemic areas have increased significantly in recent years, particularly in Southeast Asia, the Pacific, and the Americas, making DF a major emerging infectious disease. DF presents with a wide clinical spectrum, ranging from a self‐limiting infection (85‐90% of cases) to severe dengue diseases (SDD), which occurs in approximately 5% of cases, and includes both dengue shock syndrome (DSS) and dengue hemorrhagic fever (DHF). There is no effective vaccine for the prevention of dengue infection, nor are there any antiviral agents or immune modulators that can reduce its mortality. However, with good supportive medical care, mortality rates of less than 1% can be achieved, even with the inclusion of DSS cases. Therefore, diagnostic indicators are important to ensure early SDD recognition. Published studies have reported

Journal

Journal of Medical VirologyWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial